Journal List > J Korean Acad Nurs > v.47(5) > 1003268

Choi and Kweon: Effects of Education about Action Plans according to Self-Monitoring on Self-Management Adherence, Knowledge, Symptom Control, and Quality of Life among Adult Asthma Patients: A Randomized Controlled Trial

Abstract

Purpose

This study was conducted to identify the effects of education regarding action plans according to a self-monitoring program on self-management adherence, knowledge, symptom control, and health-related quality of life (HRQoL) among adults with asthma.

Methods

Thirty-four patients were randomly assigned to the intervention group and thirty-two to the control group in this study. A tailored 50-minute intervention based on the contents of self-monitoring and action plans developed by the National Heart Lung and Blood Institute was provided to the intervention group. Structured and well developed questionnaires were used to measure the dependent variables.

Results

There were no differences in all general and clinical characteristics, and the dependent variables between two groups in the pre-test. In the post-test, there were differences in the level of self-management adherence (t=4.41, p<.001), knowledge (t=2.26, p=.027), symptom control (t=-2.56, p=.013), and total HRQoL (t=2.14, p=.036) between the two groups, although there was a difference only in the sub-domain of emotion (t=2.03, p=.047) in HRQoL.

Conclusion

This study found that action plans according to self-monitoring that enhance a participatory interaction in the treatment and care could help patients with moderate to severe asthma to engagead equately in self-care, to control their symptoms, and to improve their HRQoL. Further studies are still needed to identify longitudinal effects of this program.

References

1. To T, Stanojevic S, Moores G, Gershon AS, Bateman ED, Cruz AA, et al. Global asthma prevalence in adults: Findings from the cross-sectional world health survey. BMC Public Health. 2012; 12:204. https://doi.org/10.1186/1471-2458-12-204.
crossref
2. Ministry of Health & Welfare. Korean Centers for Disease Control & Prevention. Korea National Health Statistics 2015: Korea National Health and Nutrition Examination Survey (KNHANES VI-3). Seoul: Korea Centers for Disease Control and Prevention;2016. Dec. Report No.: KNHANES 11-1351159-000027-10.
3. Masoli M, Fabian D, Holt S, Beasley R. Global Initiative for Asthma (GINA) Program. The global burden of asthma: Executive summary of the GINA Dissemination Committee report. Allergy. 2004; 59(5):469–478. https://doi.org/10.1111/j.1398-9995.2004.00526.x.
4. D’Amato G, Vitale C, Molino A, Stanziola A, Sanduzzi A, Va-trella A, et al. Asthma-related deaths. Multidisciplinary Respiratory Medicine. 2016; 11:37. https://doi.org/10.1186/s40248-016-0073-0.
crossref
5. Clark NM, Griffiths C, Keteyian SR, Partridge MR. Educational and behavioral interventions for asthma: Who achieves which outcomes? A systematic review. Journal of Asthma and Allergy. 2010; 3:187–197. https://doi.org/10.2147/JAA.S14772.
6. Peytremann-Bridevaux I, Arditi C, Gex G, Bridevaux PO, Burnand B. Chronic disease management programmes for adults with asthma. Cochrane Database of Systematic Reviews. 2015; (5). CD007988. https://doi.org/10.1002/14651858.CD007988.pub2.
crossref
7. Kim DK, Park YB, Oh YM, Jung KS, Yoo JH, Yoo KH, et al. Korean asthma guideline 2014: Summary of major updates to the Korean asthma guideline 2014. Tuberculosis and Respiratory Diseases. 2016; 79(3):111–120. https://doi.org/10.4046/trd.2016.79.3.111.
crossref
8. Reddel HK, Levy ML. Global Initiative for Asthma Scientific Committee and Dissemination and Implementation Committee. The GINA asthma strategy report: What’s new for primary care? NPJ Primary Care Respiratory Medicine. 2015; 25:15050. https://doi.org/10.1038/npjpcrm.2015.50.
9. Adams RJ, Appleton S, Wilson DH, Ruffin RE. Participatory decision making, asthma action plans, and use of asthma medication: A population survey. Journal of Asthma. 2005; 42(8):673–678. https://doi.org/10.1080/02770900500265041.
crossref
10. Taylor DR, Bateman ED, Boulet LP, Boushey HA, Busse WW, Casale TB, et al. A new perspective on concepts of asthma severity and control. European Respiratory Journal. 2008; 32(3):545–554. https://doi.org/10.1183/09031936.00155307.
crossref
11. van der Meer V, van Stel HF, Bakker MJ, Roldaan AC, As-sendelft WJ, Sterk PJ, et al. Weekly self-monitoring and treatment adjustment benefit patients with partly controlled and uncontrolled asthma: An analysis of the SMASHING study. Respiratory Research. 2010; 11:74. https://doi.org/10.1186/1465-9921-11-74.
crossref
12. National Heart Lung and Blood Institute. National asthma education and prevention program expert panel report 3: Guidelines for the diagnosis and management of asthma-summary report 2007 [Internet]. Bethesda (MD): National Heart Lung and Blood Institute;c2007. [cited 2017 Jan 1]. Available from:. https://www.nhlbi.nih.gov/files/docs/guidelines/asthsumm.pdf.
13. Arora NK, Weaver KE, Clayman ML, Oakley-Girvan I, Po-tosky AL. Physicians’ decision-making style and psychosocial outcomes among cancer survivors. Patient Education and Counseling. 2009; 77(3):404–412. https://doi.org/10.1016/j.pec.2009.10.004.
crossref
14. Kwon YS, Choi JY. Effect of self-monitoring rehabilitation program after stroke on physical function, self-efficacy and quality of life. Korean Journal of Rehabilitation Nursing. 2015; 18(2):107–117. https://doi.org/10.7587/kjrehn.2015.107.
crossref
15. Yun KS, Choi JY. Effects of dietary program based on self-efficacy theory on dietary adherence, physical indices and quality of life for hemodialysis patients. Journal of Korean Academy of Nursing. 2016; 46(4):598–609. https://doi.org/10.4040/jkan.2016.46.4.598.
crossref
16. Bandura A. Social foundations of thought and action: A social cognitive theory. Englewood Cliffs (NJ): Prentice-Hall;1986. p. 248–287.
17. Powell H, Gibson PG. Options for self-management education for adults with asthma. Cochrane Database of Systematic Reviews. 2003; (1). CD004107. https://doi.org/10.1002/14651858.CD004107.
crossref
18. Mancuso CA, Sayles W, Allegrante JP. Development and testing of the asthma self-management questionnaire. Annals of Allergy, Asthma & Immunology. 2009; 102(4):294–302. https://doi.org/10.1016/S1081-1206(10)60334-1.
crossref
19. Allen RM, Jones MP. The validity and reliability of an asthma knowledge questionnaire used in the evaluation of a group asthma education self-management program for adults with asthma. Journal of Asthma. 1998; 35(7):537–545.
crossref
20. Choi JY, Cho Chung HI. Effect of an individualised education programme on asthma control, inhaler use skill, asthma knowledge and health-related quality of life among poorly compliant Korean adult patients with asthma. Journal of Clinical Nursing. 2011; 20(1-2):119–126. https://doi.org/10.1111/j.1365-2702.2010.03420.x.
crossref
21. Juniper EF, O’Byrne PM, Guyatt GH, Ferrie PJ, King DR. Development and validation of a questionnaire to measure asthma control. European Respiratory Journal. 1999; 14(4):902–907.
crossref
22. Park JW, Cho YS, Lee SY, Nahm DH, Kim YK, Kim DK, et al. Multi-center study for the utilization of quality of life questionnaire for adult Korean asthmatics (QLQAKA). Journal of Allergy and Clinical Immunology. 2000; 20(3):467–479.
23. Patel MR, Valerio MA, Sanders G, Thomas LJ, Clark NM. Asthma action plans and patient satisfaction among women with asthma. Chest. 2012; 142(5):1143–1149. https://doi.org/10.1378/chest.11-1700.
crossref
24. Kim MY, Lee SY, Jo EJ, Lee SE, Kang MG, Song WJ, et al. Feasibility of a smartphone application based action plan and monitoring in asthma. Asia Pacific Allergy. 2016; 6(3):174–180. https://doi.org/10.5415/apallergy.2016.6.3.174.
crossref
25. Kelso JM. Do written asthma action plans improve outcomes? Pediatric Allergy, Immunology, and Pulmonology. 2016; 29(1):2–5. https://doi.org/10.1089/ped.2016.0634.
crossref
26. Yin HS, Gupta RS, Mendelsohn AL, Dreyer B, van Schaick L, Brown CR, et al. Use of a low-literacy written action plan to improve parent understanding of pediatric asthma management: A randomized controlled study. Journal of Asthma. 2017; Forthcoming. https://doi.org/10.1080/02770903.2016.1277542.
crossref
27. Raju JD, Soni A, Aziz N, Tiemstra JD, Hasnain M. A patient-centered telephone intervention using the asthma action plan. Family Medicine. 2012; 44(5):348–350.
28. Plaza V, Peiró M, Torrejón M, Fletcher M, López-Viña A, Ignacio JM, et al. A repeated short educational intervention improves asthma control and quality of life. European Respiratory Journal. 2015; 46(5):1298–1307. https://doi.org/10.1183/13993003.00458-2015.
crossref
29. Gosavi S, Nadig P, Haran A. Factors contributing towards poor asthma control in patients on regular medication. Journal of Clinical and Diagnostic Research. 2016; 10(6):OC31–OC35. https://doi.org/10.7860/JCDR/2016/18670.8052.
crossref
30. Pur Ozyigit L, Ozcelik B, Ozcan Ciloglu S, Erkan F. The effectiveness of a pictorial asthma action plan for improving asthma control and the quality of life in illiterate women. Journal of Asthma. 2014; 51(4):423–428. https://doi.org/10.3109/02770903.2013.863331.
crossref

Figure 1.
Participant selection flow.
jkan-47-613f1.tif
Table 1.
Education about Action Plans according to Self-Monitoring
Intervention Methods Contents Time Duration
Education 1:1 face to face explanation Check PEFR (peak expiratory flow rate) using At hospital visit 50 minutes
Oral presentation and skill    spirometer
   demonstration How to record DRC (diary record card)
How to choose action plans according to control,
   partial control, uncontrol groups (results)
Recording and Self-monitoring Record DRC through self-monitoring During 2~3 10~15 minutes
Adherence to Adhere to action plans according to the results    months before    per day
   written action plans    intervention
Encouragement Telephone follow-up Evaluate written action plans At 1 month after 10 minutes
Encourage adherence    intervention
Table 2.
Homogeneity of General and Disease Characteristics between Control and Intervention Group (N=66)
Characteristics Intervention group (n=34) Control group (n=32) χ2 or t or U p
n (%) or Mean±SD or Median (IQR) n (%) or Mean±SD or Median (IQR)
Gender 2.40 .122
   Male 17 (50.0) 10 (31.2)
   Female 17 (50.0) 22 (68.8)
Age (range) 24~78 23~77
Age (years) 59.88±14.12 56.38±13.55 1.03 .308
Education (years) 1.98 .576
   ≤12 6 (17.6) 7 (21.9)
   13~15 5 (14.7) 7 (21.9)
   16~18 16 (47.1) 15 (46.9)
   ≥19 7 (20.6) 3 (9.3)
Marital status .420
   Single 2 (5.9) 4 (12.5)
   Couple 32 (94.1) 28 (87.5)
Perceived economic status 3.43 .180
   High 0 (0.0) 2 (6.2)
   Middle 23 (67.6) 24 (75.0)
   Low 11 (32.4) 6 (18.8)
Occupation 0.54 .464
   Yes 15 (44.1) 17 (53.1)
   No 19 (55.9) 15 (46.9)
Perceived exposure to harmful environment 2.57 .576
   Yes 5 (14.7) 10 (31.3)
   No 29 (85.3) 22 (68.7)
Smoking status 0.52 .772
   Current smoker 1 (3.0) 2 (6.2)
   Ex-smoker 10 (29.4) 8 (25.0)
   Non-smoker 23 (67.6) 22 (68.8)
Smoking period of current and ex-smoker (months) 310.92±73.41 342.00±85.65 0.90 .382
FEV1% predicted 0.95 .331
   60~80 26 (76.5) 21 (65.6)
   <60 8 (23.5) 11 (34.4)
BMI (kg/m2) 23.11±2.61 23.53±2.22 −0.71 .479
Period of having disease (months)* 66 (96.0) 72 (90.8) 491.50 .782
Dyspnea (MRC) 1.47 .481
   Grade I 8 (23.5) 10 (31.3)
   Grade II 22 (64.7) 19 (59.4)
   Grade III 4 (11.8) 3 (9.3)
Influenza vaccination 0.53 .465
   Yes 28 (82.4) 24 (75.0)
   No 6 (17.6) 8 (25.0)
History of admission 0.63 .429
   Yes 10 (29.4) 12 (37.5)
   No 24 (70.6) 20 (62.5)
Comorbidity 0.05 .833
   Yes 14 (41.2) 14 (43.8)
   No 20 (58.8) 18 (56.2)

MRC=British medical research council.

*Value of U by Mann-Whitney test.

Fisher’s exact probability test.

Comorbidity includes myocardial infarction, congestive heart failure, peripheral vascular disease (aortic aneurysm ≥6 cm), cerebrovascular disease, dementia, Chronic pulmonary disease, connective tissue disease, peptic ulcer disease, liver disease, diabetes, hemiplegia, moderate or s severe renal disease, solid tumor, leukemia, lymphoma, liver disease, AIDS (not just HIV positive).

Table 3.
Homogeneity of Self-Management Adherence, General Knowledge, Symptom Control and Quality of Life between Interventio Group and Control Group (N=66
Variables Intervention group (n=34) Control group (n=32) t or U p
Mean±SD or Median (IQR)
Self-management adherence 6.06±2.60 6.25±2.75 −0.29 .773
General knowledge 17.97±3.65 16.72±3.57 1.41 .164
Symptom control 0.29 (0.28) 1.00 (1.07) 511.00 .674
Quality of life 67.59±11.74 64.03±15.83 1.04 .302
Symptoms 24.74±3.66 22.72±5.85 1.69 .096
Daily activity 20.74±3.88 19.75±4.70 0.93 .356
Emotion 11.12±3.50 11.19±3.52 0.08 .936
Environmental stimuli 11.00±3.12 10.38±3.02 0.83 .412

Value of U by Mann-Whitney test.

Table 4.
Comparison of Self-Management Adherence, General Knowledge, Symptom Control and Quality of Life between Intervention Group and Control Group (N=66)
Variables Program group (n=34) Control group (n=32) t or U p
Difference (Mean±SD or Median (IQR))
Self-management adherence 3.00±2.86 0.13±2.40 4.41 <.001
General knowledge 2.62±5.75 −0.03±3.40 2.26 .027
Symptom control −0.36 (0.92) 0.00 (0.71) 331.00 .006
Quality of life 8.29±12.04 2.69±8.94 2.14 .036
Symptoms 1.79±3.75 1.06±3.66 0.80 .426
Daily activity 2.26±4.91 0.34±3.19 1.87 .066
Emotion 2.29±5.07 0.38±1.79 2.03 .047
Environmental stimuli 1.94±3.01 0.91±2.10 1.61 .113

Value of U by Mann-Whitney test.

TOOLS
Similar articles